Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)

Author: Bar Jair   Damianovich Maya   Siloni Goni Hout   Dar Erel   Cohen Yehudit   Zadok Oranit   Cohen Yoram   Perelman Marina   Barshack Iris   Yarden Ronit I   Simansky David   Ben Nun Alon   Onn Amir  

Publisher: Springer Publishing Company

ISSN: 1865-5041

Source: memo - Magazine of European Medical Oncology, Vol.7, Iss.1, 2014-02, pp. : 10-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content